Ozturk, E.; Esenboga, K.; Kurtul, A.; Kilickap, M.; Karaagaoglu, E.; Karakaya, J.
Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach. Diagnostics 2023, 13, 709.
https://doi.org/10.3390/diagnostics13040709
AMA Style
Ozturk E, Esenboga K, Kurtul A, Kilickap M, Karaagaoglu E, Karakaya J.
Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach. Diagnostics. 2023; 13(4):709.
https://doi.org/10.3390/diagnostics13040709
Chicago/Turabian Style
Ozturk, Ebru, Kerim Esenboga, Alparslan Kurtul, Mustafa Kilickap, Ergun Karaagaoglu, and Jale Karakaya.
2023. "Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach" Diagnostics 13, no. 4: 709.
https://doi.org/10.3390/diagnostics13040709
APA Style
Ozturk, E., Esenboga, K., Kurtul, A., Kilickap, M., Karaagaoglu, E., & Karakaya, J.
(2023). Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach. Diagnostics, 13(4), 709.
https://doi.org/10.3390/diagnostics13040709
